Cost Minimization Analysis of Preoperative Erythropoietin vs Autologous and Allogeneic Blood Donation in Total Joint Arthroplasty

Journal of Arthroplasty

Volumn 25, Issue 1, 2010, Pages 93-96

  Green, William Scott ^a   Toy, Pearl ^a   Bozic, Kevin J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

allogeneic blood donation; autologous blood donation; cost analysis; joint arthroplasty; preoperative EPO; total

Indexed keywords

ERYTHROPOIETIN;

ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; COMPARATIVE STUDY; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PREOPERATIVE CARE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; COST SAVINGS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; ERYTHROPOIETIN, RECOMBINANT; HEMOGLOBINS; HUMANS; MIDDLE AGED; PREOPERATIVE CARE;

EID: 73149092987     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2008.10.005     Document Type: Article

References (11)

1. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am (1999) 2
2. Hardwick M.E., Morris B.M., and Colwell C.W. Two-dose epoetin alfa reduces blood transfusions compared with autologous donation. Clinical Orthopedics and Related Research (2004) 240
3. Stowell C.P., Chandler H., Jove M., et al. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty. Orthopedics 22 1 Suppl (1999) S105
4. Bozic K.J., Rosenberg A.G., Huckman R.S., et al. Current concepts review. economic evaluation in orthopedics. J Bone Joint Surg Am 85-A (2003) 129
5. Faris P.M., Ritter M.A., and Abels R.I. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J Bone Joint Surg Am 78 (1996) 62
6. Goldberg M.A., McCutchen J.W., Jove M., et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 25 (1996) 544
7. de Andrade J.R., Jove M., Landon G., et al. Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 25 (1996) 533
8. Faris P. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery. Am J Med 101 (1996) 28S
9. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 341 (1993) 1227
10. Pierson J.L., Hannon T.L., and Earles D.R. A blood-conservation algorithm to reduce blood transfusions after total hip and knee arthroplasty. J Bone and Joint Surg Am 86 (2004) 1512
11. Hatzidakis A.M., Mendlick M.R., McKillip T., et al. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am 82 (2000) 89